Mathematics of the SARS-CoV-2 Pandemic

187415-Thumbnail Image.png
Description
A pneumonia-like illness emerged late in 2019 (coined COVID-19), caused by SARSCoV-2, causing a devastating global pandemic on a scale never before seen sincethe 1918/1919 influenza pandemic. This dissertation contributes in providing deeper qualitative insights into the transmission dynamics and control

A pneumonia-like illness emerged late in 2019 (coined COVID-19), caused by SARSCoV-2, causing a devastating global pandemic on a scale never before seen sincethe 1918/1919 influenza pandemic. This dissertation contributes in providing deeper qualitative insights into the transmission dynamics and control of the disease in the United States. A basic mathematical model, which incorporates the key pertinent epidemiological features of SARS-CoV-2 and fitted using observed COVID-19 data, was designed and used to assess the population-level impacts of vaccination and face mask usage in mitigating the burden of the pandemic in the United States. Conditions for the existence and asymptotic stability of the various equilibria of the model were derived. The model was shown to undergo a vaccine-induced backward bifurcation when the associated reproduction number is less than one. Conditions for achieving vaccine-derived herd immunity were derived for three of the four FDA-approved vaccines (namely Pfizer, Moderna and Johnson & Johnson vaccine), and the vaccination coverage level needed to achieve it decreases with increasing coverage of moderately and highly-effective face masks. It was also shown that using face masks as a singular intervention strategy could lead to the elimination of the pandemic if moderate or highly-effective masks are prioritized and pandemic elimination prospects are greatly enhanced if the vaccination program is combined with a face mask use strategy that emphasizes the use of moderate to highly-effective masks with at least moderate coverage. The model was extended in Chapter 3 to allow for the assessment of the impacts of waning and boosting of vaccine-derived and natural immunity against the BA.1 Omicron variant of SARS-CoV-2. It was shown that vaccine-derived herd immunity can be achieved in the United States via a vaccination-boosting strategy which entails fully vaccinating at least 72% of the susceptible populace. Boosting of vaccine-derived immunity was shown to be more beneficial than boosting of natural immunity. Overall, this study showed that the prospects of the elimination of the pandemic in the United States were highly promising using the two intervention measures.
Date Created
2023
Agent